Senior Validation Consultant specializing in GxP computerized systems, risk-based validation strategies and regulatory compliance across Pharma and Biotech. Lead Auditor for software supplier assessments.
Effective validation starts with the right decisions: defining scope, requirements, assessing risks and establishing a practical path to compliance.
I work with QA, IT and business teams across Pharma, Biotech and MedTech to develop validation strategies aligned with regulatory expectations and operational needs.
SAP, LIMS, eQMS and other GxP computerized systems supporting manufacturing, laboratory and quality operations require a validation strategy that aligns business objectives, regulatory expectations and implementation timelines.
New projects require a risk-based validation approach, clear responsibilities and a practical roadmap before execution begins.
Existing systems, documentation or processes require a structured gap assessment to identify risks, remediation actions and compliance priorities.
FDA, EMA or other regulatory inspections require organizations to demonstrate a clear validation state, robust documentation, effective data integrity controls and audit readiness.
New technologies and shared responsibility models require a validation concept aligned with GxP requirements and regulatory expectations.
Organizations need to optimize validation approaches, reduce unnecessary effort and implement efficient, risk-based practices while maintaining compliance.
Intelligent validation approaches that connect business needs, technology and regulatory expectations.
Full-scope audits of software, SaaS and PaaS vendors for pharmaceutical organizations, covering SDLC, Quality Management Systems (QMS), risk management, supplier management, infrastructure, backup and disaster recovery.
Assessments performed against GxP requirements, GAMP 5, EU GMP Annex 11, FDA 21 CFR Part 11 and ISO 9001.
Defining validation strategies for complex GxP environments, including Validation Master Plans (VMP), governance models, risk-based approaches and lifecycle management across manufacturing, laboratory and quality systems — from enterprise-wide strategy down to the validation of individual systems.
Supporting digital transformation in regulated environments by validating new enterprise platforms, system upgrades and technology-enabled processes.
Aligning business objectives, IT implementation and regulatory expectations to achieve compliant go-live and sustainable operation.
Supporting the qualification of cloud environments and infrastructure supporting GxP systems, including AWS services, servers, databases, networks, backup and disaster recovery processes.
Applying risk-based approaches aligned with GAMP 5 infrastructure qualification principles and supplier responsibility models.
Performing independent CSV gap assessments and regulatory compliance reviews to identify risks, define remediation priorities and strengthen validation maturity.
Supporting organizations in addressing gaps against current GxP expectations, data integrity principles and regulatory requirements.
Preparing computerized systems and validation documentation for FDA inspections and regulatory audits — ensuring system validation records, data integrity controls and audit trails withstand scrutiny.
Experience supporting FDA pre-approval inspection (PAI) readiness specifically for validated computerized systems, within the broader site inspection effort.
Experience across diverse GxP computerized systems and technology environments, supporting laboratory, manufacturing, quality and enterprise operations.
GxP laboratory platforms, including LIMS, CDS (chromatography data systems) and analytical systems
PMS, SCADA, process control and monitoring systems (e.g. Sartorius MFCS)
eQMS, document management and validation platforms
ERP, PLM, WMS and business-critical applications
Cloud platforms, infrastructure and services supporting GxP applications
AI/ML-enabled systems and evolving validation approaches aligned with current GxP expectations